GlycoNex Incorporation 4168.TWO Stock
GlycoNex Incorporation Price Chart
GlycoNex Incorporation 4168.TWO Financial and Trading Overview
| GlycoNex Incorporation stock price | 26.25 TWD |
| Previous Close | 31 TWD |
| Open | 30.85 TWD |
| Bid | 30.75 TWD x N/A |
| Ask | 30.8 TWD x N/A |
| Day's Range | 30.75 - 31.3 TWD |
| 52 Week Range | 24.25 - 46.9 TWD |
| Volume | 555.4K TWD |
| Avg. Volume | 803.98K TWD |
| Market Cap | 3.32B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.64 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 5, 2013 |
| 1y Target Est | N/A |
4168.TWO Valuation Measures
| Enterprise Value | 3.32B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.2781153 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
GlycoNex Incorporation Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 13.04% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 46.9 TWD |
| 52 Week Low | 24.25 TWD |
| 50-Day Moving Average | 31.29 TWD |
| 200-Day Moving Average | 32.13 TWD |
4168.TWO Share Statistics
| Avg. Volume (3 month) | 803.98K TWD |
| Avg. Daily Volume (10-Days) | 445.6K TWD |
| Shares Outstanding | 107.84M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 21.44% |
| % Held by Institutions | 0.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1100:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.3 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 13.97M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -2.43 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 13.498 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of GlycoNex Incorporation
| Country | Taiwan |
| State | N/A |
| City | New Taipei City |
| Address | No. 97, Xintai 5th Road |
| ZIP | 221 |
| Phone | 886 2 2697 4168 |
| Website | https://www.glyconex.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GlycoNex Incorporation develops cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan. Its technology platform enables glycan-directed cancer therapy and analytical tools for glycosylation. The company develops GNX102, a humanized antibody for cancer; and GNX201, GNX202, GNX203, and GNX204 for various solid tumors. It also develops Denosumab, a humanized IgG2 antibody that is in preclinical stage for the treatment of osteoporosis and oncology; and Aflibercept, a vascular endothelial growth factor binding fusion protein for the treatment of ophthalmology and oncology. GlycoNex Incorporation was founded in 2001 and is based in New Taipei City, Taiwan.
Q&A For GlycoNex Incorporation Stock
What is a current 4168.TWO stock price?
GlycoNex Incorporation 4168.TWO stock price today per share is 26.25 TWD.
How to purchase GlycoNex Incorporation stock?
You can buy 4168.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GlycoNex Incorporation?
The stock symbol or ticker of GlycoNex Incorporation is 4168.TWO.
Which industry does the GlycoNex Incorporation company belong to?
The GlycoNex Incorporation industry is Biotechnology.
How many shares does GlycoNex Incorporation have in circulation?
The max supply of GlycoNex Incorporation shares is 108.21M.
What is GlycoNex Incorporation Price to Earnings Ratio (PE Ratio)?
GlycoNex Incorporation PE Ratio is now.
What was GlycoNex Incorporation earnings per share over the trailing 12 months (TTM)?
GlycoNex Incorporation EPS is -1.64 TWD over the trailing 12 months.
Which sector does the GlycoNex Incorporation company belong to?
The GlycoNex Incorporation sector is Healthcare.